Bicara Therapeutics Inc. ...

NASDAQ: BCAX · Real-Time Price · USD
9.74
-0.26 (-2.60%)
At close: Jun 17, 2025, 3:01 PM

Bicara Therapeutics Common Stock Revenue

Bicara Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Bicara Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
55
Market Cap
530.99M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.